0001209191-18-049379.txt : 20180904
0001209191-18-049379.hdr.sgml : 20180904
20180904194350
ACCESSION NUMBER: 0001209191-18-049379
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180830
FILED AS OF DATE: 20180904
DATE AS OF CHANGE: 20180904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SteadyMed Investors, LLC
CENTRAL INDEX KEY: 0001637025
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36889
FILM NUMBER: 181053596
BUSINESS ADDRESS:
STREET 1: 1780 GREEN BAY ROAD
CITY: HIGHLAND PARK
STATE: IL
ZIP: 60035
BUSINESS PHONE: 512-338-9090
MAIL ADDRESS:
STREET 1: 1780 GREEN BAY ROAD
CITY: HIGHLAND PARK
STATE: IL
ZIP: 60035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SteadyMed Ltd.
CENTRAL INDEX KEY: 0001619087
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 OPPENHEIMER STREET
CITY: REHOVOT
STATE: L3
ZIP: 76701
BUSINESS PHONE: (925) 272-4991
MAIL ADDRESS:
STREET 1: 5 OPPENHEIMER STREET
CITY: REHOVOT
STATE: L3
ZIP: 76701
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-30
0
0001619087
SteadyMed Ltd.
STDY
0001637025
SteadyMed Investors, LLC
C/O STEADYMED LTD.
2603 CAMINO RAMON, SUITE 350
SAN RAMON
CA
94583
0
0
1
0
Ordinary Shares
2018-08-30
4
S
0
266257
4.46
D
0
I
See Footnote.
Ordinary Shares
2018-08-30
4
S
0
2088258
4.46
D
0
I
See Footnote.
Ordinary Shares
2018-08-30
4
S
0
181025
4.46
D
0
I
See Footnote.
Warrants to Purchase Ordinary Shares
3.5995
2018-08-30
4
J
0
266257
0.125
D
2021-08-03
Ordinary Shares
266527
0
I
See Footnote.
Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation ("United"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the "Merger Agreement"). Under the Merger Agreement, at the effective time of the merger (the "Effective Time"), each outstanding ordinary share of the Issuer was converted into the right to receive (1) $4.46 in cash plus (2) one contractual contingent value right (a "CVR"), which represents the right to receive $2.63 in cash upon the achievement of a specified milestone (the "Milestone").
By SteadyMed Investors III LLC, an affiliate of SteadyMed Investors, LLC.
By SteadyMed Investors, LLC. KB Partners, LLC is the Managing Member and the Reporting Person is the Managing Member of KB Partners, LLC.
By SteadyMed Investors II, LLC, an affiliate of SteadyMed Investors LLC.
Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation ("United"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the "Merger Agreement"). At the Effective Time, each outstanding warrant to purchase ordinary shares of the Issuer issued in 2016 was converted into the right to receive $2.71.
/s/ David W. Nassif, Attorney-In-Fact
2018-09-04